Wall Street is positive on Clover Health Investments Corp (CLOV). On average, analysts give Clover Health Investments Corp a Buy rating. The average price target is $3.5, which means analysts expect the stock to gain by 18.64% over the next twelve months. That average ranking earns Clover Health Investments Corp an Analyst Rating of 13, which is better than 13% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating CLOV a Buy today. Find out what this means to you and get the rest of the rankings on CLOV!